The usually observed modifications of the deep phlebogram in the entire pathological series are: transmedial displacement of the internal cerebral vein (more or less evident but always significant), straightening of the superior arch of the internal cerebral vein, an important ventricular dilatation in most cases. The most reliable parameters are: Fisher's bisecting line and two of the parameters proposed by the author's: Monro-Phleboaxial-Line and Monro-Glabella-Bregma-Angle.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Cancer Mortality Rates in Female Veterans With and Without TBI.
JAMA Netw Open
March 2025
Informatics, Decision-Enhancement, and Analytic Sciences Center of Innovation, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah.
Very Late-Onset Neurodegeneration with Brain Iron Accumulation Associated with Mild Chorea: A Clinicopathological Case.
Mov Disord Clin Pract
March 2025
Unit of Pathology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Background: Neurodegeneration with Brain Iron Accumulation (NBIA) rarely manifests after the age of 50 years. The phenotype in these cases is most often parkinsonism.
Objectives: To present the case with the oldest age of NBIA onset reported so far.
Dried blood spot sampling offers a scalable strategy to close diagnostic gaps and improve global surveillance for cardiovascular-kidney-metabolic syndrome. However, assay performance and the extent of validity vary widely between biomarkers used in cardiovascular-kidney-metabolic health assessment under different settings and have not been well described. To fill this gap, we conducted a systematic search of the literature and a narrative synthesis through April 2024 and included reports with laboratory or field validation measuring biomarkers that can be used in cardiovascular-kidney-metabolic health assessment.
View Article and Find Full Text PDFChinese herbal medicine for the treatment of children with cerebral palsy: a meta-analysis of randomized controlled trials with core herbs exploration.
Front Pharmacol
February 2025
Division of Chinese Internal and Pediatric Medicine, Center for Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
Introduction: Chinese herbal medicine (CHM) taken orally is frequently utilized to enhance functional ability and independence in cerebral palsy (CP); nonetheless, there is a lack of current evidence regarding the efficacy of oral CHM in treating CP. Additionally, the general complexities of CHM prescriptions often obscure the underlying mechanisms. Our study aims to assess the efficacy of oral CHM in treating CP, a meta-analysis will be conducted on randomized clinical trials (RCTs).
View Article and Find Full Text PDFClarity Amidst the Smoke: Moyamoya Disease, a Diagnosis Not to Be Missed.
Cureus
February 2025
Internal Medicine, Farwaniya Hospital, Kuwait City, KWT.
Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder characterized by the bilateral stenosis of the internal carotid artery (ICA) and its proximal vessels, leading to the formation of compensatory smoke-like collateral vessels. This report describes the case of a 33-year-old Philippine woman who presented with acute right-sided hemiparesis and had a history of recurrent transient ischemic attacks (TIAs) with similar symptoms. Neuroimaging revealed intracranial hemorrhage and characteristic bilateral occlusion of the internal carotid artery (ICA), middle cerebral artery (MCA), and anterior cerebral artery (ACA) with collateral vessel formation, indicative of moyamoya disease.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!